arrow
K

Keith Casper

university of michigan system
H指数:27
被引数:2,556

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Validation of MyHPVscore: a high-performance HPV ctDNA lab developed test

MyHPVscore验证:一种高性能HPV ctDNA实验室开发检测

2026-05-040
OAAI
Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios Predict Improved Survival and Response to Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of the Larynx

中性粒细胞与淋巴细胞比值及淋巴细胞与单核细胞比值可预测局部晚期喉鳞状细胞癌患者诱导化疗后的生存改善和疗效反应。

2025-12-010
OAAI
Tumor Hypoxia and CD8+ T-Cell Infiltration in Patients With Advanced Laryngeal Cancer

肿瘤缺氧和CD8+ T细胞浸润在晚期喉癌患者中的研究

2025-05-050
OAAI
ctDNA transiting into urine is ultrashort and facilitates noninvasive liquid biopsy of HPV+ oropharyngeal cancer
2024-02-085
OA
Initial Feasibility and Acute Toxicity Outcomes From a Phase 2 Trial of 18F-Fluorodeoxyglucose Positron Emission Tomography Response- Based De-escalated Definitive Chemoradiotherapy for p16+Oropharynx Cancer: A Planned Interim Analysis
2023-09-012
PRE
Development of a high-performance multi-probe droplet digital PCR assay for high-sensitivity detection of human papillomavirus circulating tumor DNA from plasma
2023-08-019
OAAI
Patterns of recurrence in head and neck squamous cell carcinoma to inform personalized surveillance protocols

头颈部鳞状细胞癌的复发模式,以告知个性化监测方案

CANCER
IF5.1
2023-05-1021
OAAI
Prognostic value of CD103+ tumor-infiltrating lymphocytes and programmed death ligand-1 (PD-L1) combined positive score in recurrent laryngeal squamous cell carcinoma

CD103肿瘤浸润淋巴细胞和程序性死亡ligand-1 (PD-L1) 联合阳性评分对复发性喉鳞状细胞癌的预后价值

2022-12-018
OAAI
Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer
2022-09-1511
OA